Founded in 2004, SomnoMed® is an Australian Stock Exchange listed medical device company operating in 28 countries.
With headquarters in Sydney, Australia and offices in Europe and the United States, SomnoMed® focuses on developing and manufacturing clinically proven medical devices for the treatment of Obstructive Sleep Apnea (OSA). More than 625,000 patients around the world with mild and moderate OSA have been successfully treated with our oral appliances.
SomnoMed® leads the world in the development of OSA devices with each appliance custom made using state-of-the-art technology delivering precision, comfort, and first-time fit solutions. SomnoMed®’s continuous improvement has ensured oral sleep medicine devices have greater efficacy and are more comfortable than ever. Our devices are 510(k) cleared by the FDA (Food and Drug Administration), TGA (Therapeutic Goods Administration) listed and manufactured in accordance with ISO 13485 quality standards.
At SomnoMed®, we are committed to providing comfortable and effective OSA treatment that is effective and clinically proven to treat Obstructive Sleep Apnea (OSA). Our passion is to help patients regain their lives again by having a comfortable night sleep.
